Dr. Rachel Brem’s Mission to Improve Breast Cancer Screening
Dr. Rachel Brem’s determination to improve breast cancer detection began at a young age. After her mother was diagnosed with breast cancer, early detection helped her mother exceed her prognosis. Now, Brem works to enhance screening for all women.
As a board-certified diagnostic radiologist, she leads the Breast Imaging and Intervention at George Washington University. She established the Brem Foundation to combat breast cancer fatalities. On the podcast “Healthful,” she shares insights into innovations making her optimistic.
The Role of Artificial Intelligence in Breast Imaging
Brem emphasizes the transformative potential of artificial intelligence in medicine, particularly in breast cancer detection. Her work includes collaborating with ScreenPoint Medical on Transpara, an AI software for breast cancer screening.
Scientific studies indicate that mammograms combined with AI evaluations detect cancer up to five years earlier. The software identifies warning signs unseen by traditional mammograms and predicts future breast cancer risk.
She notes that beginning screenings at age 35 with AI-enhanced methods could impact survival rates. At George Washington University, AI has been integral to mammograms for over four years without additional costs.
Nationwide, however, only 20% of practices integrate AI with their procedures due to extra costs, making it less accessible for some.
Addressing Inequality and Expanding Access
Brem acknowledges that while no absolute prevention exists for breast cancer, AI can mitigate inequalities. She highlights racial disparities, with Black women having a 40% higher mortality rate than White women and those with fewer resources facing access challenges.
The Brem Foundation aims to change this by promoting early detection through innovative screening, education, and equitable access for the past 20 years.
Developing a Breast Cancer Breath Test
One of Brem’s projects involves creating a breath test for breast cancer detection. Diseased tissues emit chemical compounds that could provide a noninvasive screening method. The test aims to eliminate pain, compression, and injections in diagnostics.
There is also potential for the breath test to assess broader women’s health concerns in the future, providing multiple diagnostics from one breath sample.
Current Breast Cancer Screening Guidelines
The American College of Physicians recommends mammograms every other year for women over 50, and the United States Preventive Services Task Force urges screenings starting at age 40. Brem warns against these guidelines, advocating annual screenings from 40 and even earlier for those with family history.
Anxiety often deters women from getting screened. Yet, early detection significantly improves outcomes, with 99% of women diagnosed early surviving and thriving. Women with dense breasts should pursue additional tests like ultrasounds, MRIs, or enhanced mammograms, as regular mammograms might miss tumors.
Empowerment through Education and Self-Advocacy
Brem stresses the importance of self-advocacy for effective breast cancer outcomes. Women should demand necessary screenings, especially those with dense breasts, and start considering screening options before reaching 40.
Proactivity is key. Early diagnosis is crucial, as younger women face increasing cancer rates. Education and proactive measures are essential. The Brem Foundation offers resources to support women in these efforts.
Brem emphasizes self-advocacy at medical appointments, encouraging women to assert their needs and rights. She champions the motto: “Be badass.” Advocacy is fundamental; it’s about deserving and obtaining necessary healthcare support.